Additionally, the ROC analysis showed a significant improvement in the ability to identify NAFLD using the ALT/HDL-C ratio (AUC=0.8553) compared to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.